Article Details

US FDA grants 'breakthrough' status to Neuralink's speech restoration device

Retrieved on: 2025-05-02 13:44:29

Tags for this article:

Click the tags to see associated articles and topics

US FDA grants 'breakthrough' status to Neuralink's speech restoration device. View article details on hiswai:

Excerpt

The US Food and Drug Administration (FDA) has granted 'breakthrough device' status to Neuralink's experimental speech restoration device.

Article found on: thetechportal.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo